|Mr. Juan Jose Chacon Quiros||Founder, CEO & Exec. Director||841.32k||N/A||1972|
|Mr. Rajbir Singh Denhoy||Chief Financial Officer||421.42k||N/A||1970|
|Mr. Pratip Dastidar||Head of Global Operations||424.49k||N/A||1963|
|Mr. Roberto de Mezerville||Chief Technology Officer||N/A||N/A||1981|
|Ms. Neeta Toprani||Gen. Counsel & Corp. Sec.||N/A||N/A||N/A|
|Mr. Jeffrey Clark Bettinger||Global Head of People||N/A||N/A||N/A|
|Mr. Salvador Santos Dada||Chief Operating Officer (Medical Leave of Absence)||N/A||N/A||1983|
|Dr. Heather Brennan||Head of U.S. Commercial Operations||N/A||N/A||N/A|
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Establishment Labs Holdings Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.